Back

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion

17 March 2019 (14:25 - 14:30)
Organised by:
Congress Presentation Part of: Late-breaking trials 1 Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Jose Luis Merino

La Paz University Hospital, Madrid (Spain)

10 More presentations in this session

Presentation thumbnail
A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study
Doctor J. Andrade (Vancouver, CA)
Slides Video
Presentation thumbnail
CIRCA-DOSE Study - Discussion
Professor D. Scherr (Graz, AT)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF
Professor P. Kanagaratnam (London, GB)
Slides Video
Presentation thumbnail
Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry
Professor L. Boersma (Nieuwegein, NL)
Slides Video
Presentation thumbnail
GOLD AF registry - Discussion
Slides Video

Access the full session

Session thumbnail
Late-breaking trials 1

The Event

Event poster

EHRA 2019

17 March 2019 14:25 CET
You may be interested in
thumbnail
Congress Session
Periprocedural management of catheter ablation of atrial fibrillation (AF)
3 April 2022
thumbnail
Congress Presentation
31 August 2019
thumbnail
Congress Session
Management of atrial fibrillation in heart failure
19 May 2025
thumbnail
Congress Presentation
Comparison of early rhythm control strategies in patients with atrial fibrillation: a nationwide population-based cohort study
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources